Auckland-based, ASX-listed soft tissue regeneration company Aroa Biosurgery grew first half product revenue by 110% as it invests into the American surgical market.
The company, which joined the Australian exchange in July last year, grew its product revenue by 96% to $17.7m and cut its loss by
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
